Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Return on Equity: 2021-2025

Historic Return on Equity for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to 0.09%.

  • Cellebrite DI's Return on Equity rose 10.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -1.53% for FY2024, which is 321.00% up from last year.
  • Per Cellebrite DI's latest filing, its Return on Equity stood at 0.09% for Q3 2025, which was up 146.69% from -0.20% recorded in Q2 2025.
  • Cellebrite DI's Return on Equity's 5-year high stood at 25.12% during Q2 2022, with a 5-year trough of -2.79% in Q1 2022.
  • Over the past 3 years, Cellebrite DI's median Return on Equity value was -0.20% (recorded in 2025), while the average stood at -0.19%.
  • Per our database at Business Quant, Cellebrite DI's Return on Equity spiked by 397bps in 2022 and then plummeted by 2,531bps in 2023.
  • Over the past 5 years, Cellebrite DI's Return on Equity (Quarterly) stood at -0.66% in 2021, then spiked by 247bps to 1.81% in 2022, then crashed by 213bps to -0.32% in 2023, then decreased by 27bps to -0.59% in 2024, then climbed by 10bps to 0.09% in 2025.
  • Its last three reported values are 0.09% in Q3 2025, -0.20% for Q2 2025, and -0.37% during Q1 2025.